JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,121,000 | -67.8% | 308,927 | -68.4% | 0.02% | -71.6% |
| Q3 2017 | $43,807,000 | +2311.0% | 976,524 | +1506.3% | 0.07% | +2133.3% |
| Q2 2017 | $1,817,000 | +116.6% | 60,794 | +60.8% | 0.00% | +50.0% |
| Q1 2017 | $839,000 | +122.5% | 37,796 | +89.0% | 0.00% | +100.0% |
| Q4 2016 | $377,000 | -55.2% | 20,000 | -28.7% | 0.00% | 0.0% |
| Q3 2016 | $842,000 | -32.6% | 28,045 | -13.7% | 0.00% | -50.0% |
| Q2 2016 | $1,249,000 | -49.4% | 32,482 | -49.8% | 0.00% | -50.0% |
| Q1 2016 | $2,468,000 | +194.2% | 64,769 | +239.4% | 0.00% | +300.0% |
| Q4 2015 | $839,000 | -73.4% | 19,086 | -75.4% | 0.00% | -80.0% |
| Q3 2015 | $3,151,000 | +1393.4% | 77,433 | +2122.5% | 0.01% | – |
| Q1 2015 | $211,000 | – | 3,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |